Prognostic Value of Volume-based Positron Emission Tomography/computed Tomography in Patients with Nasopharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy

Overview

Journal Clin Exp Otorhinolaryngol

Date 2015 Jun 6

PMID 26045913

Citations 15

Authors

Seung Hwan Moon

Joon Young Choi

Hwan Joo Lee

Young-Ik Son

Chung-Hwan Baek

Yong Chan Ahn

Myung-Ju Ahn

Keunchil Park

Byung-Tae Kim

Affiliations

Soon will be listed here.

Abstract

Objectives: The aim of this study was to evaluate the prognostic value of volume-based metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) in patients with nasopharyngeal carcinoma (NPC).

Methods: Forty-four NPC patients who underwent (18)F-FDG PET/CT for initial staging work-up before concurrent chemoradiotherapy (CCRT) were retrospectively evaluated. Maximum standardized uptake value (SUV), mean SUV, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of the primary tumors were measured. The prognostic significance and predictive performance of these parameters were assessed by Cox proportional hazards regression analysis and time-dependent receiver operating characteristics (ROC) curve analysis.

Results: Multivariate analysis showed that American Joint Committee on Cancer stage 7th edition (hazard ratio [HR], 1.525; 95% confidence interval [CI], 1.062 to 2.188; P=0.022), and TLG (HR, 7.799; 95% CI, 2.622 to 23.198; P≤0.001) were independent predictive factors associated with decreased disease-free survival (DFS). Time-dependent ROC curve analysis indicated that TLG was a better predictor of DFS than MTV (P=0.008).

Conclusion: The TLG of the primary tumor was a significant independent metabolic prognostic factor of DFS in patients with NPC treated with CCRT.

Citing Articles

F-FDG PET/CT metabolic parameters can semi-quantitatively evaluate the nature of the heart and pericardial masses: a retrospective study.

Hu X, Yang P, Pan D, Wang P Sci Rep. 2024; 14(1):16316.

PMID: 39009884 PMC: 11251084. DOI: 10.1038/s41598-024-67336-8.

Multiple Testing, Cut-Point Optimization, and Signs of Publication Bias in Prognostic FDG-PET Imaging Studies of Head and Neck and Lung Cancer: A Review and Meta-Analysis.

Clausen M, Vogelius I, Kjaer A, Bentzen S Diagnostics (Basel). 2020; 10(12).

PMID: 33271785 PMC: 7761090. DOI: 10.3390/diagnostics10121030.

Radiomics Analysis and Correlation With Metabolic Parameters in Nasopharyngeal Carcinoma Based on PET/MR Imaging.

Feng Q, Liang J, Wang L, Niu J, Ge X, Pang P Front Oncol. 2020; 10:1619.

PMID: 33014815 PMC: 7506153. DOI: 10.3389/fonc.2020.01619.

Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy.

Alessi A, Lorenzoni A, Cavallo A, Padovano B, Iacovelli N, Bossi P Radiol Med. 2018; 124(5):414-421.

PMID: 30560502 DOI: 10.1007/s11547-018-0980-6.

PET-based prognostic survival model after radiotherapy for head and neck cancer.

Castelli J, Depeursinge A, Devillers A, Campillo-Gimenez B, Dicente Y, Prior J Eur J Nucl Med Mol Imaging. 2018; 46(3):638-649.

PMID: 30132054 DOI: 10.1007/s00259-018-4134-9.

References

La T, Filion E, Turnbull B, Chu J, Lee P, Nguyen K . Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009; 74(5):1335-41. PMC: 2752334. DOI: 10.1016/j.ijrobp.2008.10.060. View

Kim Y, Kim B, Jung S, Lee Y, Kim M, Sun D . Radiation therapy combined with (or without) cisplatin-based chemotherapy for patients with nasopharyngeal cancer: 15-years experience of a single institution in Korea. Cancer Res Treat. 2009; 40(4):155-63. PMC: 2697480. DOI: 10.4143/crt.2008.40.4.155. View

Hyun S, Choi J, Shim Y, Kim K, Lee S, Cho Y . Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol. 2009; 17(1):115-22. DOI: 10.1245/s10434-009-0719-7. View

Zheng Y, Cai T, Feng Z . Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers. Biometrics. 2006; 62(1):279-87. DOI: 10.1111/j.1541-0420.2005.00441.x. View

Al-Sarraf M, Reddy M . Nasopharyngeal carcinoma. Curr Treat Options Oncol. 2002; 3(1):21-32. DOI: 10.1007/s11864-002-0038-8. View

Chan S, Chang J, Wang H, Lin C, Ng S, Fan K . Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value. Oral Oncol. 2008; 45(1):52-8. DOI: 10.1016/j.oraloncology.2008.03.010. View

Schwartz D, Rajendran J, Yueh B, Coltrera M, LeBlanc M, Eary J . FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg. 2004; 130(12):1361-7. DOI: 10.1001/archotol.130.12.1361. View

Lee A, Law S, Foo W, Poon Y, Cheung F, Chan D . Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence. Int J Radiat Oncol Biol Phys. 1993; 26(5):773-82. DOI: 10.1016/0360-3016(93)90491-d. View

Allal A, Slosman D, Kebdani T, Allaoua M, Lehmann W, Dulguerov P . Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys. 2004; 59(5):1295-300. DOI: 10.1016/j.ijrobp.2003.12.039. View

10.

Moon S, Choi J, Lee H, Son Y, Baek C, Ahn Y . Prognostic value of 18F-FDG PET/CT in patients with squamous cell carcinoma of the tonsil: comparisons of volume-based metabolic parameters. Head Neck. 2012; 35(1):15-22. DOI: 10.1002/hed.22904. View

11.

Lu H, Peng L, Yuan X, Hao Y, Lu Z, Chen J . Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia. Cancer Treat Rev. 2009; 35(4):345-53. DOI: 10.1016/j.ctrv.2009.01.002. View

12.

Lee H, Hyun S, Lee K, Kim B, Kim J, Shim Y . Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications. Ann Surg Oncol. 2010; 17(10):2787-94. DOI: 10.1245/s10434-010-1107-z. View

13.

Choi K, Yoo I, Han E, Kim Y, Kim G, Na S . Prognostic Value of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery. Nucl Med Mol Imaging. 2014; 45(1):43-51. PMC: 4042945. DOI: 10.1007/s13139-010-0063-7. View

14.

Sham J, Choy D . Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival. Head Neck. 1991; 13(4):298-310. DOI: 10.1002/hed.2880130406. View

15.

Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K . [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol. 2005; 23(6):1136-43. DOI: 10.1200/JCO.2005.06.129. View

16.

Juweid M, Stroobants S, Hoekstra O, Mottaghy F, Dietlein M, Guermazi A . Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 2007; 25(5):571-8. DOI: 10.1200/JCO.2006.08.2305. View

17.

Liu M, Hsieh C, Chang T, Lin J, Huang C, Wang A . Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol. 2003; 33(10):501-8. DOI: 10.1093/jjco/hyg092. View

18.

Lee P, Weerasuriya D, Lavori P, Quon A, Hara W, Maxim P . Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007; 69(2):328-33. DOI: 10.1016/j.ijrobp.2007.04.036. View

19.

Chan S, Chang J, Lin C, Ng S, Wang H, Liao C . Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification. Nucl Med Commun. 2011; 32(11):989-96. DOI: 10.1097/MNM.0b013e3283495662. View

20.

Chu S, Wu P, Chou P, Lee C . Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for recurrence and survival rate. Eur Arch Otorhinolaryngol. 2008; 265 Suppl 1:S115-20. DOI: 10.1007/s00405-008-0590-3. View